APA

Noriega V., Martínez-Laperche C., Buces E., Pion M., Sánchez-Hernández N., Martín-Antonio B., Guillem V., Bosch-Vizcaya A., Bento L., González-Rivera M., Balsalobre P., Kwon M., Serrano D., Gayoso J., de la Cámara R., Brunet S., Rojas-Contreras R., Nieto J. B., Martínez C., Gónzalez M., Espigado I., Vallejo J. C., Sampol A., Jiménez-Velasco A., Urbano-Ispizua A., Solano C., Gallardo D., Díez-Martín J. L. & Buño I. (20160628). The Genotype of the Donor for the (GT)n Polymorphism in the Promoter/Enhancer of FOXP3 Is Associated with the Development of Severe Acute GVHD but Does Not Affect the GVL Effect after Myeloablative HLA-Identical Allogeneic Stem Cell Transplantation. : PloS one.

Chicago

Noriega Víctor, Martínez-Laperche Carolina, Buces Elena, Pion Marjorie, Sánchez-Hernández Noemí, Martín-Antonio Beatriz, Guillem Vicent, Bosch-Vizcaya Anna, Bento Leyre, González-Rivera Milagros, Balsalobre Pascual, Kwon Mi, Serrano David, Gayoso Jorge, de la Cámara Rafael, Brunet Salut, Rojas-Contreras Rafael, Nieto José B, Martínez Carmen, Gónzalez Marcos, Espigado Ildefonso, Vallejo Juan C, Sampol Antonia, Jiménez-Velasco Antonio, Urbano-Ispizua Alvaro, Solano Carlos, Gallardo David, Díez-Martín José L and Buño Ismael. 20160628. The Genotype of the Donor for the (GT)n Polymorphism in the Promoter/Enhancer of FOXP3 Is Associated with the Development of Severe Acute GVHD but Does Not Affect the GVL Effect after Myeloablative HLA-Identical Allogeneic Stem Cell Transplantation. : PloS one.

Harvard

Noriega V., Martínez-Laperche C., Buces E., Pion M., Sánchez-Hernández N., Martín-Antonio B., Guillem V., Bosch-Vizcaya A., Bento L., González-Rivera M., Balsalobre P., Kwon M., Serrano D., Gayoso J., de la Cámara R., Brunet S., Rojas-Contreras R., Nieto J. B., Martínez C., Gónzalez M., Espigado I., Vallejo J. C., Sampol A., Jiménez-Velasco A., Urbano-Ispizua A., Solano C., Gallardo D., Díez-Martín J. L. and Buño I. (20160628). The Genotype of the Donor for the (GT)n Polymorphism in the Promoter/Enhancer of FOXP3 Is Associated with the Development of Severe Acute GVHD but Does Not Affect the GVL Effect after Myeloablative HLA-Identical Allogeneic Stem Cell Transplantation. : PloS one.

MLA

Noriega Víctor, Martínez-Laperche Carolina, Buces Elena, Pion Marjorie, Sánchez-Hernández Noemí, Martín-Antonio Beatriz, Guillem Vicent, Bosch-Vizcaya Anna, Bento Leyre, González-Rivera Milagros, Balsalobre Pascual, Kwon Mi, Serrano David, Gayoso Jorge, de la Cámara Rafael, Brunet Salut, Rojas-Contreras Rafael, Nieto José B, Martínez Carmen, Gónzalez Marcos, Espigado Ildefonso, Vallejo Juan C, Sampol Antonia, Jiménez-Velasco Antonio, Urbano-Ispizua Alvaro, Solano Carlos, Gallardo David, Díez-Martín José L and Buño Ismael. The Genotype of the Donor for the (GT)n Polymorphism in the Promoter/Enhancer of FOXP3 Is Associated with the Development of Severe Acute GVHD but Does Not Affect the GVL Effect after Myeloablative HLA-Identical Allogeneic Stem Cell Transplantation. : PloS one. 20160628.